Press "Enter" to skip to content

New patent expiration for Mylan Speciality drug ELESTRIN

0
Copyright © DrugPatentWatch. Originally published at New patent expiration for Mylan Speciality drug ELESTRIN

Annual Drug Patent Expirations for ELESTRIN
Annual Drug Patent Expirations for ELESTRIN

Elestrin is a drug marketed by Mylan Speciality Lp and is included in one NDA. It is available from one supplier. There are two patents protecting this drug.

ELESTRIN drug price trends.

Drug patent litigation for ELESTRIN.

This drug has fifty-two patent family members in twenty countries.

The generic ingredient in ELESTRIN is estradiol. One supplier is listed for this compound. Additional details are available on the estradiol profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent expiration for Mylan Speciality drug ELESTRIN
Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

DrugPatentWatch - Make Better Decisions